Characteristics | Number of cases | CDK16 expression | p value | |
---|---|---|---|---|
Low (n = 36) | High (n = 36) | |||
Age (years) | Â | Â | Â | 0.339 |
  ≥ 65 | 42 | 19 | 23 |  |
  < 65 | 30 | 17 | 13 |  |
Gender | Â | Â | Â | 0.234 |
 Male | 58 | 27 | 31 |  |
 Female | 14 | 9 | 5 |  |
Tumor size | Â | Â | Â | 0.077 |
  ≥ 5 cm | 49 | 21 | 28 |  |
  < 5 cm | 23 | 15 | 8 |  |
Edmondson Grade | Â | Â | Â | 0.023* |
 I-II | 57 | 31 | 26 |  |
 III-IV | 20 | 5 | 15 |  |
Encapsulation | Â | Â | Â | 0.020* |
 Yes | 51 | 30 | 21 |  |
 No | 21 | 6 | 15 |  |
Tumor number | Â | Â | Â | 0.042* |
 Singular | 57 | 32 | 25 |  |
 Multifocal | 15 | 4 | 11 |  |
HBV infection | Â | Â | Â | 0.781 |
 Positive | 55 | 27 | 28 |  |
 Negtive | 17 | 9 | 8 |  |
BCLC stage | Â | Â | Â | 0.107 |
 A | 57 | 32 | 28 |  |
 B and C | 10 | 2 | 8 |  |
Cirrhosis | Â | Â | Â | 0.800 |
 Yes | 49 | 24 | 25 |  |
 No | 23 | 12 | 11 |  |
Serum AFP(μg/L) |  |  |  | 0.437 |
  ≥ 400 | 51 | 27 | 24 |  |
  < 400 | 21 | 9 | 12 |  |
PVTT | Â | Â | Â | 0.029* |
 Yes | 9 | 1 | 8 |  |
 No | 63 | 35 | 27 |  |